Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors(PDE5I) in Male Subjects

NCT00767598 is registered in ClinicalTrials.gov with Inje University as lead sponsor.

NCT NCT00767598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00767598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors(PDE5I) in Male Subjects
Lead sponsor
Inje University
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2007
Completion date
July 31, 2008
Enrollment
21 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

genetic polymorphic cyp3a5, healthy subjects, pharmacokinetics of three pde5is